Wagner Wealth Management (South Carolina)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-210
Closed -$18K 708
2021
Q1
$18K Buy
+210
New +$18.8K 0.01% 376
2018
Q3
$10K Buy
135
+78
+137% +$5.77K 0.01% 422
2018
Q2
$4K Sell
57
-123
-68% -$8.49K ﹤0.01% 477
2018
Q1
$13K Buy
180
+11
+7% +$837 0.01% 344
2017
Q4
$21K Buy
+169
New +$12.8K 0.02% 300

Other funds holding NVS

Wagner Wealth Management (South Carolina)'s NVS Position: Q2 2021 in Review

Wagner Wealth Management (South Carolina) sold out of Novartis (NVS) in Q2 2021, closing a stake of 210 shares — an estimated $18K sold.

Wagner Wealth Management (South Carolina) first reported a position in NVS in Q4 2017 and held it in 5 quarters. The position peaked at $21K in Q4 2017. 1,120 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

  • Wagner Wealth Management (South Carolina) reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 210 Novartis shares in Q2 2021, an estimated $18K.
  • Wagner Wealth Management (South Carolina) first reported a position in Novartis in Q4 2017 and held it in 5 quarters.
  • Wagner Wealth Management (South Carolina)'s Novartis position peaked at $21K in Q4 2017.
  • 1,120 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q2 2021, filed 13 Aug 2021.